Search the Newsreel

ePlus inc (PLUS) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of ePlus inc (PLUS), highlighting its current price momentum score as 3.61 and placing it within the Software & IT Services industry. The analysis identifies key support at $81.36 and resistance at $94.59, suggesting a range-bound swing trading …

Nuveen Core Plus Impact Fund Revenue Breakdown – NYSE:NPCT

This article provides a brief overview of the Nuveen Core Plus Impact Fund (NPCT) on TradingView, focusing on its financial data, market status, and available tools for analysis. It notes that the market is currently closed with no trades. The article also lists various …

PSTV|Plus Therapeutics Inc|Price:3.770|Chg%:-0.060

Plus Therapeutics Inc. (PSTV) is a clinical-stage pharmaceutical company focused on developing targeted radiotherapeutics for difficult-to-treat cancers of the central nervous system. The company's lead candidates, REYOBIQ and Rhenium-188 NanoLiposome Biodegradable Alginate Microsphere, target conditions like leptomeningeal metastases, glioblastoma, and solid organ cancers. As …

Asset Plus Limited Revenue Breakdown – NZX:APL

ePlus inc (PLUS) Income Statement

This article provides a detailed quarterly and annual income statement for ePlus inc (PLUS), offering insights into its financial performance, including revenue, operating expenses, and net income. It also includes an FAQ section explaining how to read the income statement and defining key financial …

Simulations Plus, Inc. $SLP Stock Position Boosted by First Light Asset Management LLC

First Light Asset Management LLC significantly increased its stake in Simulations Plus, Inc. (NASDAQ:SLP) by 33.7% in the first quarter, now owning 13.03% of the company. Despite this, analyst sentiment has weakened, with a consensus "Reduce" rating and an average price target of $17.25. …

Plus Therapeutics Inc (PSTV) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides an overview of Plus Therapeutics Inc (PSTV)'s dividend history and stock split events. It indicates that the company has not distributed any dividends in the past five years. However, it lists several past and upcoming merger-related stock splits with various ratios.

PLUS | ePlus Inc Executive Compensation

This page provides an overview of ePlus Inc (PLUS) executive compensation, noting that specific details are based on recent SEC DEF 14A filings. It also mentions the estimated median employee salary at ePlus and lists various financial and government contract data points related to …

Plus Therapeutics Inc (PSTV) Income Statement

This article provides the quarterly and annual income statements for Plus Therapeutics Inc (PSTV), offering detailed financial data such as total revenue, operating expenses, R&D expenses, and net income over numerous fiscal periods. The data helps users analyze the company's performance and operational efficiency. …

Plus Therapeutics Inc (PSTV) Shareholder Structure: Major Shareholders & Institutional Holdings

This article details the shareholder structure of Plus Therapeutics Inc (PSTV), listing major shareholders and their respective proportions. It also provides a breakdown of shareholder types, institutional shareholding over time, and recent shareholder activities including changes in holdings by key institutions.

Telecom Plus PLC Revenue Breakdown – LSE:TEP

Capstone Energy Plus, Inc. Revenue Breakdown – NASDAQ:CEPL

Capstone Energy Plus, Inc. (NASDAQ:CEPL) generated $106.00 million USD in revenue last year. The Product and Accessories - Microturbine segment was the top performer, contributing $53.93 million USD. The United States was the largest regional contributor, accounting for $70.13 million USD of the total …

TradingKey: Simulations Plus Inc (SLP) Income Statement Analysis

This article provides an in-depth look at the quarterly and annual income statements for Simulations Plus Inc (SLP) from TradingKey, detailing revenue, cost of revenue, operating expenses, and net income figures over several fiscal years. It offers a comprehensive financial summary, including year-over-year changes …

ePlus inc. Revenue Breakdown – NASDAQ:PLUS

ePlus inc. (NASDAQ: PLUS) reported total revenue of $2.44 billion USD last year. The largest portion of this revenue, $1.98 billion USD, came from its "Third-party Hardware, Third-party Perpetual and Subscription Software, and Third-party Maintenance, Software Assurance, and Other Third-party Services" segment. The United …

Did ePlus’ (PLUS) Expanded Share Authorization Quietly Redefine Its Capital Flexibility Playbook?

ePlus Inc. (PLUS) received board approval to increase its authorized common shares from 50 million to 75 million at its 2026 Annual Meeting of Shareholders, subject to shareholder approval. This move aims to provide the company with greater financial flexibility for future initiatives like …

ePlus inc (PLUS) Financial Health: Profitability & Balance Sheet Analysis

ePlus inc (PLUS) has a robust financial status with a current financial score of 8.72, ranking 59th out of 485 in the Software & IT Services industry. The company reported a quarterly revenue of $581.63M, marking a 16.77% year-over-year increase, and a net profit …

LG Uplus Corp Revenue Breakdown – KRX:032640

ePlus announces annual shareholder meeting

ePlus has announced its 2026 annual shareholder meeting will be held on September 10, 2026, in Herndon, Virginia. Key agenda items include the election of nine directors, an advisory vote on executive compensation, and the ratification of Deloitte as the independent auditor. Shareholders will …

EPLUS INC SEC Filing (Jul 24, 2026)

This article reports on an SEC filing (Form type ARS) by EPLUS INC (PLUS) on July 24, 2026. The filing has a low impact and neutral sentiment according to Rhea-AI. The article also provides recent news and other SEC filings for EPLUS INC, along …

ePlus inc. (PLUS) Stock Price, News, Quote & History

This Yahoo Finance page provides a comprehensive overview of ePlus inc. (PLUS) stock, including its current price, historical performance, key financial metrics, and company overview. It details the company's IT solutions across three segments: Product Services, Professional Services, and Managed Services, and presents analyst …

PLUS THERAPEUTICS Inc. (PSTV) Stock Price | Live Quotes & Charts | NASDAQ

The NASDAQ page for PLUS THERAPEUTICS Inc. (PSTV) shows a live stock price of $3.83, an increase of $0.05 (1.26%). The stock currently has no analyst ratings or earnings information available. The page also features general information about trading and disclaimers about the risks …

PLUS|ePlus inc|Price:86.930|Chg%:-0.680

ePlus inc. (PLUS) is a technology solutions and services company offering AI, security, cloud, and networking solutions, along with various managed and professional services. The article provides an overview of the company's profile, including its market cap, P/E ratio, key executives, and institutional shareholdings. …

ePlus inc (PLUS) Earnings Date & Reports & Earnings News

Earnings Release: Here's Why Analysts Cut Their MedPlus Health Services Limited (NSE:MEDPLUS) Price Target To ₹1,013

Plus Therapeutics Inc (PSTV) Valuation: PE, PB & Fair Value Analysis

The article provides a valuation analysis for Plus Therapeutics Inc (PSTV), noting its current valuation score of 9.94, which ranks 5th in the Biotechnology & Medical Research industry. It highlights the company's P/E ratio of -1.09, while indicating that P/B, P/S, and P/CF data …

Simulations Plus Sets Shareholder Vote on Cash Merger with Altaris Affiliate

Simulations Plus has scheduled a virtual special shareholder meeting for August 27, 2026, to vote on a proposed cash merger with SP Evolution BidCo II, LLC, an affiliate of Altaris. The deal, which offers shareholders $18.50 per share, representing a 26% premium, is unanimously …

Medplus Q1FY27 revenue rises 21.8%, PAT falls 21.7%

Plus Therapeutics, Inc. (PSTV) Stock Price, News, Quote & History

This Yahoo Finance page provides comprehensive financial data for Plus Therapeutics, Inc. (PSTV), including its current stock price, historical performance, key financial metrics, and analyst ratings. The company is a clinical-stage pharmaceutical firm focused on developing treatments for various cancers, with rhenium obisbemeda as …

MedPlus Shares Fall Over 17% After Q1 Net Profit Declines 21%

MedPlus Health shares tumble 16% after Q1 profit falls 21% YoY. Should you buy, sell or hold?

Medplus Health Services shares tumble to 52-week low after weak Q1 FY27; Nomura maintains 'Buy', check target price

Medplus Health Services consolidated net profit declines 21.67% in the June 2026 quarter

MedPlus Health Shares Slide 16% on Q1 Profit Decline Despite Revenue Growth - Tech Earnings Analysis

Plus Therapeutics Secures Regional Coverage Agreement with Medical Mutual for CNSide® Cerebrospinal Fluid Assay for Metastatic CNS Cancer

Plus Therapeutics, through its subsidiary CNSide Diagnostics, LLC, has signed a regional agreement with Medical Mutual to cover its CNSide® Cerebrospinal Fluid Assay for metastatic CNS cancer. This agreement expands the test's coverage to approximately 1.2 million people in Ohio and Kentucky, bringing the …

ePlus Inc. (PLUS) Recognized in 2026 MES Midmarket 100 for AI Solutions

ePlus Inc. (PLUS) has been recognized in the 2026 MES Midmarket 100 list by MES Computing for its expertise in assisting mid-sized businesses with AI program planning and deployment. The company's GF Score™ is 83/100, indicating strong potential for long-term returns, but GuruFocus considers …

WCM Investment Management LLC Sells 142,693 Shares of ePlus inc. $PLUS

WCM Investment Management LLC significantly reduced its stake in ePlus inc. by 44.7% in the first quarter, selling 142,693 shares, though it still holds 176,750 shares valued at approximately $13.0 million. This comes as ePlus reported stronger-than-expected quarterly results and increased its dividend, yet …